Cholecystokinin potently releases somatostatin from canine fundic mucosal cells in short-term culture

Am J Physiol. 1985 May;248(5 Pt 1):G569-73. doi: 10.1152/ajpgi.1985.248.5.G569.

Abstract

Previous studies indicated that gastrin-17 (G-17) and the octapeptide of colecystokinin (CCK-8) were equally potent in their interaction with receptors for 125I-[Leu15]G-17 on isolated canine parietal cells. These findings were inconsistent with the poor efficacy of CCK-8 compared with G-17 as stimuli of acid secretion in dogs. The present study examines the effects of G-17 and CCK-8 on the release of somatostatinlike immunoreactivity (SLI) from a fraction of small canine fundic mucosal cells separated by elutriation and placed in short-term culture. CCK-8 was considerably more potent and more effective than G-17 as a stimulant of SLI release from these cultured cells. CCK-8 was slightly more potent than G-17 in inhibiting 125I-[Leu15]G-17 binding to receptors in the same elutriator fraction. Our present findings support the hypothesis that the poor efficacy of CCK compared with G-17 as a stimulant of acid secretion may reflect pronounced activation of somatostatin-mediated acid-inhibitory mechanisms by CCK-8. The present data indicate that differences in affinity between CCK-8 and G-17 at the 125I[Leu15]G-17 receptor probably do not account for the greater efficacy of CCK-8; the receptor or cell activation mechanisms underlying this greater efficacy of CCK-8 on SLI release remain to be elucidated.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cells, Cultured
  • Dogs
  • Epinephrine / pharmacology
  • Gastric Fundus / drug effects
  • Gastric Fundus / metabolism
  • Gastric Mucosa / drug effects
  • Gastric Mucosa / metabolism*
  • Gastrins / pharmacology
  • Sincalide / pharmacology*
  • Somatostatin / metabolism*
  • Time Factors

Substances

  • Gastrins
  • Somatostatin
  • gastrin 17
  • Sincalide
  • Epinephrine